BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 20604928)

  • 1. Up-regulation and subcellular localization of hnRNP A2/B1 in the development of hepatocellular carcinoma.
    Cui H; Wu F; Sun Y; Fan G; Wang Q
    BMC Cancer; 2010 Jul; 10():356. PubMed ID: 20604928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous nuclear ribonucleoprotein A2/B1 in association with hTERT is a potential biomarker for hepatocellular carcinoma.
    Mizuno H; Honda M; Shirasaki T; Yamashita T; Yamashita T; Mizukoshi E; Kaneko S
    Liver Int; 2012 Aug; 32(7):1146-55. PubMed ID: 22372738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splicing factor hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma development.
    Shilo A; Ben Hur V; Denichenko P; Stein I; Pikarsky E; Rauch J; Kolch W; Zender L; Karni R
    RNA; 2014 Apr; 20(4):505-15. PubMed ID: 24572810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of HnRNP A1 promotes tumor invasion through regulating CD44v6 and indicates poor prognosis for hepatocellular carcinoma.
    Zhou ZJ; Dai Z; Zhou SL; Fu XT; Zhao YM; Shi YH; Zhou J; Fan J
    Int J Cancer; 2013 Mar; 132(5):1080-9. PubMed ID: 22821376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of heterogeneous nuclear ribonucleoprotein A2/B1 protein in the pathogenesis of non-small cell lung cancer].
    Shi Y; Chen Y; Hou YY; Ji CH; Hu Q; Zhou Y; Su JA; Tan YS
    Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):110-4. PubMed ID: 21575478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of hnRNP A2/B1 proteins in small airway epithelial cells.
    Satoh H; Ishikawa H; Kamma H; Fujiwara M; Homma S; Kagohashi K; Ohtsuka M; Sekizawa K
    Int J Mol Med; 2004 Oct; 14(4):605-8. PubMed ID: 15375589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and effect of heterogeneous nuclear ribonucleoprotein A2/B1 in tongue squamous cell carcinoma.
    Liu Y; Shen X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):633-640. PubMed ID: 37539565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deregulated expression of hnRNP A/B proteins in human non-small cell lung cancer: parallel assessment of protein and mRNA levels in paired tumour/non-tumour tissues.
    Boukakis G; Patrinou-Georgoula M; Lekarakou M; Valavanis C; Guialis A
    BMC Cancer; 2010 Aug; 10():434. PubMed ID: 20716340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and diagnostic relevance of hnRNP A2/B1, hnRNP B1 and S100 A2 in non-small cell lung cancer.
    Zech VF; Dlaska M; Tzankov A; Hilbe W
    Cancer Detect Prev; 2006; 30(5):395-402. PubMed ID: 17067748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cilostazol inhibits the expression of hnRNP A2/B1 and cytokines in human dermal microvascular endothelial cells.
    An Y; Zheng Z; Zhang X; Cho SB; Kim DY; Choi MJ; Bang D
    Clin Exp Rheumatol; 2017; 35 Suppl 108(6):60-66. PubMed ID: 28850024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hnRNP A2/B1 interacts with influenza A viral protein NS1 and inhibits virus replication potentially through suppressing NS1 RNA/protein levels and NS1 mRNA nuclear export.
    Wang Y; Zhou J; Du Y
    Virology; 2014 Jan; 449():53-61. PubMed ID: 24418537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of hnRNP A2/B1 expression in tumor cells under prolonged hypoxia.
    Garayoa M; Man YG; Martínez A; Cuttitta F; Mulshine JL
    Am J Respir Cell Mol Biol; 2003 Jan; 28(1):80-5. PubMed ID: 12495935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers.
    Sueoka E; Goto Y; Sueoka N; Kai Y; Kozu T; Fujiki H
    Cancer Res; 1999 Apr; 59(7):1404-7. PubMed ID: 10197602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma.
    Wright JH; Johnson MM; Shimizu-Albergine M; Bauer RL; Hayes BJ; Surapisitchat J; Hudkins KL; Riehle KJ; Johnson SC; Yeh MM; Bammler TK; Beyer RP; Gilbertson DG; Alpers CE; Fausto N; Campbell JS
    Int J Cancer; 2014 Feb; 134(4):778-88. PubMed ID: 23929039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of heterogeneous nuclear ribonucleoprotein A2/B1 vs loss of E-cadherin: their reciprocal immunoexpression profiles in human pancreatic cancer.
    Gu W; Liu W; Shen X; Shi Y; Wang L; Liu H
    Ann Diagn Pathol; 2013 Feb; 17(1):14-7. PubMed ID: 22622045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The localization of hnRNP A2/B1 in nuclear matrix and the aberrant expression during the RA-induced differentiation of human neuroblastoma SK-N-SH cells.
    Liang Y; Shi SL; Li QF; Chen LY; Jing GJ; Tan GW; Wang SY; Wu FY
    J Cell Biochem; 2011 Jul; 112(7):1722-9. PubMed ID: 21321999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHD1L prevents lipopolysaccharide-induced hepatocellular carcinomar cell death by activating hnRNP A2/B1-nmMYLK axis.
    Wang G; Zhang X; Cheng W; Mo Y; Chen J; Cao Z; Chen X; Cui H; Liu S; Huang L; Liu M; Ma L; Ma NF
    Cell Death Dis; 2021 Sep; 12(10):891. PubMed ID: 34588420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Inflammation and Bone Erosion by RNA Interference-Mediated Silencing of Heterogeneous Nuclear RNP A2/B1 in Two Experimental Models of Rheumatoid Arthritis.
    Herman S; Fischer A; Presumey J; Hoffmann M; Koenders MI; Escriou V; Apparailly F; Steiner G
    Arthritis Rheumatol; 2015 Sep; 67(9):2536-46. PubMed ID: 26017221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.
    Shi X; Ran L; Liu Y; Zhong SH; Zhou PP; Liao MX; Fang W
    Oncol Rep; 2018 Mar; 39(3):939-950. PubMed ID: 29328485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.